Crossmark

Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic

Crossref DOI link: https://doi.org/10.1016/j.medcli.2022.05.016

Published Print: 2022-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Kow, Chia Siang

Ramachandram, Dinesh Sangarran

Hasan, Syed Shahzad
License Information

Text and Data Mining valid from 2022-11-01
More Information

This article is maintained by: Elsevier

Article Title: Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2022.05.016

Content Type: simple-article

Copyright: © 2022 Elsevier España, S.L.U. All rights reserved.